MSN Labs Gets SEC Go-Ahead to Conduct Phase IV Clinical Trial on Elagolix for Endometriosis
- 01 November 2025
- 28 minutes from now
Boehringer Ingelheim Told to File Separate Phase IV Trial Plan for Empagliflozin
- 01 November 2025
- 25 minutes from now
Another tragedy in Chhindwara: Infant dies after taking Ayurvedic formulation
- 01 November 2025
- 23 minutes from now
Nearly 50% of Drug Inspector Posts Vacant at CDSCO, Reveals RTI Response
- 01 November 2025
- 23 minutes from now
MSN Labs appoints Kalakuntla Srinivas Rao as Executive Vice President - Formulations Manufacturing Operations
- 01 November 2025
- 8 hours ago
JnJ seeks USFDA nod for Stelara in treatment of pediatric ulcerative colitis
- 01 November 2025
- 8 hours ago
Sanofi India net profit falls 7.9 percent in Q2
- 31 October 2025
- 23 hours ago
Boehringer Ingelheim acquires license from Kyowa Kirin to develop autoimmune diseases treatment
- 31 October 2025
- 23 hours ago
Recent News
Madras HC grants bail to man accused of forging NE...
- 01 November, 2025
AIIMS INI SS January 2026: 4 seats added in 2 spec...
- 01 November, 2025
Treatment in Myocardial Infarction and Non-Obstruc...
- 01 November, 2025
PG medical admissions 2025 commence in Bihar, chec...
- 01 November, 2025
Assam to begin NEET PG 2025 counselling from Novem...
- 01 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.









